Pink Sheet
Scrip
Medtech Insight
HBW Insight
Generics Bulletin
In Vivo
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Relmada’s Phase III Depression Study Scuppered By ‘Placebo Paradox’
Adjunctive Studies Will Continue
Oct 14 2022
•
By
Andrew McConaghie
After years of no new therapies, major depressive disorder is seeing advances again. • Source: Shutterstock
Keep up with the top pharma business news of the week. On the go.
Scrip brings you a weekly bulletin of top picks.
More from Neurological
More from Therapy Areas